MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Marketable securities,current$174,397K Cash and cashequivalents$61,274K Prepaid expenses andother current assets$6,817K Accounts receivable$2,883K Total current assets$245,371K Right-of-use asset$39,090K Marketable securities,non-current$32,600K Property and equipment,net$4,492K Other assets$3,865K Restricted cash$3,443K Total assets$328,861K Total liabilities andstockholders equity$328,861K Total stockholdersequity$234,247K Total liabilities$94,614K Accumulated deficit-$763,822K Accumulated othercomprehensive income-$322K Additional paid-in capital$998,381K Operating leaseliability, net of current$51,925K Total currentliabilities$27,249K Deferred revenue, net ofcurrent$15,440K Common stock, par valueof 0.0001 per share...$10K Deferred revenue,current$10,124K Accrued expenses andother current...$9,830K Operating leaseliability, current$6,522K Accounts payable$773K
Balance Sheet

C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics, Inc. (CCCC)

source: myfinsight.com